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Introduction
- Human papillomavirus (HPV) is the most common
sexually transmitted infection in the United States,
with over 79 million Americans infected today.1
- The majority of the people infected with the virus are
people in their late teens or early 20s.1
- Although HPV often goes away on its own, it has the
potential to cause serious health problems such as
genital warts and cancers.1,2
- Vaccination can decrease infections of certain high-risk
HPV strains.1
- Although the CDC recommends that individuals
between 9-26 years old should receive the HPV
vaccine, catch-up vaccination until 45 years old is
available upon further guidance from healthcare
providers.3

Purpose
The purpose of this study was to investigate:
- The frequency of general and HPV vaccination
discussion in a primary care setting
- The rationale for recommending or not
recommending the HPV vaccine
- Who prompted the vaccination discussion

Results
Figure 1. Frequency of general vaccination and
HPV vaccination discussions

- Standardized patient (SP) encounters (n=28) were
randomly sampled from 134 video recordings of rising
third-year medical student trainees from 2017.
- Students were prompted to take a patient history for a
32-year-old establishing care in a primary care setting
who had not seen a physician in over a decade.
- If the student did not cover vaccinations, the SP
prompted a general vaccine discussion at the end of
the encounter by asking “what shots do I need?”
- Encounter content of general and HPV vaccination
discussions were coded for recommendation(s),
rationale, and who prompted the discussion.
- The UofL IRB approved this study

Figure 2. Rationale composition for not
suggesting HPV vaccine

(of 28 SP encounters)

(of 27 vaccination discussions)

- Vaccination was discussed 96% of the time
- Vaccine discussion was prompted by the patient
64% of the time, while the student prompted the
discussion only 32% of the time
- From the encounters that had a vaccine discussion,
14.8% of students discussed the HPV vaccine.

- Of the 24 students who did not recommend
the HPV vaccine, 71% said that there was not
enough vaccination records, 21% had no
vaccination discussion or did not provide any
recommendations, and 8% said that the SP
was out of the recommendation range.

- These data illustrated gaps in HPV and general vaccination
discussion among medical trainees.
- HPV vaccination discussion was limited to patients with a
cervix, which is a prominent missed opportunity to discuss
HPV vaccination with patients who were assigned male at
birth since males also can contract and spread the virus.
- Additionally, the SPs in these encounters had not received
vaccinations for over a decade so there was also a missed
opportunity in catching patients that had not received care
since before the vaccine’s debut.
- These trends may be reflected in primary care settings,
and we thus recommend that routine vaccination
history/discussion include the HPV vaccine for new
patients establishing care.

Future Study
Future studies will examine additional encounters to compare
HPV vaccination discussion and recommendations through:
- Connections between LGBT+ patient identity
- Comparing trends among student gender identity and
patient identity

Table 1. Frequency of HPV vaccination recommendation as a factor of SP SAAB
Patient’s Sex Assigned at Birth (SAAB)

Methods

Discussion

HPV vaccine
recommended

HPV vaccine
not recommended

HPV vaccine
not discussed

Female SAAB

4

2

14

Male SAAB

0

0

8

- HPV vaccine discussion was limited to patients with who were assigned female at birth
- Of the patients who were recommended to get an HPV vaccine (n=4), all were assigned female at birth.

GAPS IN HPV AND
GENERAL VACCINATION
DISCUSSION

MISSED OPPORTUNITIES
TO DISCUSS HPV VACCINE
WITH MALE SAAB PATIENTS

ROUTINE VACCINE
DISCUSSION SHOULD
INCLUDE HPV VACCINE
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